Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GLOBAL-BLOOD-THERAPEUTICS-23320379/news/GBT-s-Inclacumab-and-GBT601-Receive-U-S-FDA-Orphan-Drug-and-Rare-Pediatric-Disease-Designations-for-40661302/?utm_source=whatsapp&utm_medium=social&utm_campaign=share